Abstract

New Cartridge-Ready Technologies Enable Faster Assay Development and Superior Product Performance

Richard Spero, CEO, Redbud Labs

Microfluidic platform investment continues to accelerate, yet the menu of available tests remains limited. Is there a way to streamline microfluidic product development so that tests are developed more rapidly, implemented on-cartridge more successfully, and manufactured more reliably? Cartridge-ready assay development enables the use of proven, efficient methods in the early discovery phase, while ensuring a smooth transition through integration onto a microfluidic cartridge and into volume manufacturing. We demonstrate new methods for rapid assay development and cartridge integration that enables high-performance implementation of multiple high-sensitivity life science assays.